Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Research Institute

Neither a doctor nor a teaching hospital

Research payments

$2,359,345

698 payments

Through program year 2025, Advanced Research Institute is reported as receiving $2,359,345 in research payments, across 698 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$125,760	25
2024	Research	$96,441	87
2023	Research	$119,590	21
2022	Research	$48,768	6
2021	Research	$399,139	104
2020	Research	$646,112	243
2019	Research	$923,535	212

Breakdown

Who paid Research payments · program years 2019–2025

AbbVie, Inc. $687,308 238 payments
Ironwood Pharmaceuticals, Inc $399,226 13 payments
Dexcom, Inc. $240,024 22 payments
Braintree Laboratories, Inc. $167,947 26 payments
AstraZeneca Pharmaceuticals LP $160,067 9 payments
Incyte Corporation $147,701 23 payments
Allergan Inc. $144,080 11 payments
Bausch Health US, LLC $102,617 84 payments
Novo Nordisk AS $96,967 199 payments
E.R. Squibb & Sons, L.L.C. $53,884 4 payments

Studies the money was for Research payments · program years 2019–2025

C3718-301 $318,431 9 payments
M16-283 $190,165 49 payments
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis. $139,080 10 payments
Bli4900-301 $123,164 20 payments
M16-100 $106,686 8 payments
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis $92,917 83 payments
Coach $87,749 1 payment
TRuE AD2-An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis $74,762 16 payments
A Phase II Randomised Double blind Placebo controlled Study to Evaluate the Efficacy Safety and Tolerability of AZD5004 in Participants living with Obesity or Overweight with Comorbidity $71,906 1 payment
McP-103-205 $65,499 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.